ESLA
Estrella Immunopharma Inc.
0.481$
+2.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | – | – | – | – | – | |
| – | +106.7% | +130.8% | +298.3% | +0.0% | -48.2% | |
| – | +106.7% | +215.2% | – | – | – | |
| – | – | +408.9% | -1,825.1% | – | +1,105.2% | |
| – | – | – | – | – | -100.0% | |
| – | +16,447.6% | – | – | – | – | |
| – | – | +144,351.8% | -99.0% | -39.5% | -86.3% | |
| – | – | – | – | – | – | |
| – | +724.4% | -743.1% | – | -101.1% | – | |
| – | +0.0% | -110.7% | – | -48.0% | -46.7% | |
| – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.